BCHE and obesity due to melanocortin 4 receptor deficiency: Moreover, alongside its involvement in AD progression, an emerging role of BChE as a prognostic marker (which determines the progress of the disease) in liver and non-liver diseases, as well as in protein-energy malnutrition and obesity, has been reported15,59.